ACTRN12610000671066
Not yet recruiting
Not Applicable
Fenofibrate effects on endothelial progenitor cell (EPC) number and function in patients with recent diagnosis of type 2 diabetes mellitus (T2DM).
Prof Anthony Keech0 sites22 target enrollmentAugust 16, 2010
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Prof Anthony Keech
- Enrollment
- 22
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Recently diagnosed type 2 diabetes mellitus in adults.
- •2\) No previous recent exposure to or any current definite indication for statins or fibrates
Exclusion Criteria
- •1\) Age less than 18 years
- •2\) Pregnant women(based on urine Beta Human Choriogonadotrophin test (HCG))
- •3\) Cognitively impaired, homeless people or others considered unlikely to comply.
- •4\) Acute myocardial infarction within the last 3 months
- •5\) Anemia with Hemoglobin \< 110 mg/dl
- •6\) Significant renal impairment (estimated Glomerular Filtration Rate\<60 ml/min/1\.73m^2\)
- •7\) Active liver disease
- •8\) Clinical gallbladder disease
- •9\)Known hypersensitivity to statin or fibrate therapy
- •10\) Severe hypertriglyceridaemia and/or pancreatitis requiring fibrate therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 4
Effect of Fenofibrate on Endothelial Dysfunction and Oxidative Stress in patients with Type 2 Diabetes Mellitus: an open label studytype 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12612000734864ita Cristina27
Completed
Phase 3
A study to investigate the effect of taking fenofibrate on abnormal artery blood vessel function in people with Type 2 diabetes who are on best-dose treatment with statin medications.Endothelial dysfunction in Type 2 DiabetesMetabolic and Endocrine - DiabetesACTRN12606000387527Professor Gerald Watts25
Active, not recruiting
Phase 1
Effects on endothelial progenitor cells by statins in all with acute coronary syndromeEUCTR2016-000355-27-GBniversity Hospitals of North Midlands NHS Trust40
Completed
Not Applicable
PARADISE in Kagoshima studyhyperlipidemia, Type 2 Diabetes MellitusJPRN-jRCTs071190049ishio Yoshihiko100
Active, not recruiting
Not Applicable
Endothelial progenitor cells mobilization induced by atorvastatin in patients with chronic coronaric disease (stable angina) treated with revascularization with antibody antiCD34 covered stent - NDcoronaric chronic diseaseMedDRA version: 6.1Level: PTClassification code 10011078EUCTR2007-002519-22-ITOSPEDALE POLICLINICO S. MATTEO